- Home
- FTRE vs MLNK Comparison
FTRE vs MLNK Comparison
Compare FTRE & MLNK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- MLNK
- Stock Information
- Founded
- FTRE 1996
- MLNK 1998
- Country
- FTRE United States
- MLNK United States
- Employees
- FTRE N/A
- MLNK N/A
- Industry
- FTRE Medical Specialities
- MLNK Computer Software: Prepackaged Software
- Sector
- FTRE Health Care
- MLNK Technology
- Exchange
- FTRE Nasdaq
- MLNK Nasdaq
- Market Cap
- FTRE 469.0M
- MLNK N/A
- IPO Year
- FTRE N/A
- MLNK 2021
- Fundamental
- Price
- FTRE $5.95
- MLNK $17.23
- Analyst Decision
- FTRE Hold
- MLNK Hold
- Analyst Count
- FTRE 11
- MLNK 7
- Target Price
- FTRE $18.00
- MLNK $21.21
- AVG Volume (30 Days)
- FTRE 2.3M
- MLNK 180.7K
- Earning Date
- FTRE 05-12-2025
- MLNK 05-12-2025
- Dividend Yield
- FTRE N/A
- MLNK N/A
- EPS Growth
- FTRE N/A
- MLNK N/A
- EPS
- FTRE N/A
- MLNK N/A
- Revenue
- FTRE $2,696,400,000.00
- MLNK $316,298,000.00
- Revenue This Year
- FTRE N/A
- MLNK $6.07
- Revenue Next Year
- FTRE $3.32
- MLNK $5.81
- P/E Ratio
- FTRE N/A
- MLNK N/A
- Revenue Growth
- FTRE N/A
- MLNK 4.18
- 52 Week Low
- FTRE $4.77
- MLNK $15.57
- 52 Week High
- FTRE $37.24
- MLNK $25.33
- Technical
- Relative Strength Index (RSI)
- FTRE 43.28
- MLNK 52.88
- Support Level
- FTRE $5.40
- MLNK $16.16
- Resistance Level
- FTRE $6.38
- MLNK $16.93
- Average True Range (ATR)
- FTRE 0.45
- MLNK 0.41
- MACD
- FTRE 0.21
- MLNK 0.14
- Stochastic Oscillator
- FTRE 72.52
- MLNK 88.82
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.